Fintel reports that on February 13, 2025, UBS upgraded their outlook for Interpublic Group of Companies (NYSE:IPG) from Sell to Neutral. Analyst Price Forecast Suggests 29.60% Upside As of January 29, ...
Fintel reports that on February 13, 2025, UBS initiated coverage of Jasper Therapeutics (NasdaqCM:JSPR) with a Buy ...